Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas

Purpose: To evaluate the prevalence and the role of undifferentiated connective tissue dysplasia in the pathogenesis of recurrent erysipelas.Materials and Methods: This retrospective study includes patients with primary and recurrent erysipelas who checked up during a period of 24 months. Patient’s...

Full description

Bibliographic Details
Main Authors: A. B. Ashirova, S. N. Orlova
Format: Article
Language:English
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2012-03-01
Series:Медицинский вестник Юга России
Subjects:
Online Access:https://www.medicalherald.ru/jour/article/view/1113
Description
Summary:Purpose: To evaluate the prevalence and the role of undifferentiated connective tissue dysplasia in the pathogenesis of recurrent erysipelas.Materials and Methods: This retrospective study includes patients with primary and recurrent erysipelas who checked up during a period of 24 months. Patient’s level of free hydroxyproline in blood serum was checked by the colorimetric method of T.P. Kuznetsova.Results: The number of dysembryogenetic stigma in patients with recurrent erysipelas was significantly more than in patients with primary erysipelas. The highest level of hydroxyproline was in patients with recurrent erysipelas.Summary: Patients with erysipelas are characterizes by connective tissue dysplasia. In patients with erysipelas identified changes in the indicators of collagen metabolism, indicating their partial degradation. Increased levels of free hydroxyproline in patients’ blood with erysipelas reflects the destruction of tissue and cellular structures of skin as a result of acute bacterial inflammation.
ISSN:2219-8075
2618-7876